glp-1-rezeptoragonisten Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025) GLP-1-Rezeptoragonisten und kardiometabolische Gesundheit –

Are uncomfortable with compounded medications: If you have concerns about using medications that haven't undergone FDA review as finished products, or you strongly prefer FDA-approved options for peace of mind, brand-name Wegovy or Zepbound (if you can access them affordably) would be more appropriate than compounded formulations

WADA PROHIBITED Section S2 (2025 Prohibited List) Ipamorelin is explicitly named on the World Anti-Doping Agency (WADA) Prohibited List 2025 under Section S2 Peptide Hormones, Growth Factors, Related Substances and Mimetics as a prohibited growth-hormone secretagogue

Aortic-valve stenosis from patients at risk to severe valve obstruction

*Any medication beyond the initial 3 months will be prescribed by your doctor based on your needs